New MRI technique could help doctors see inside Crohn's disease
NCT ID NCT07413653
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will use powerful MRI scans on intestinal tissue removed during surgery from 60 people with Crohn's disease. The goal is to better tell apart active inflammation from permanent scarring, which is hard to do with current scans. By comparing MRI results with detailed tissue analysis, researchers hope to improve future imaging so doctors can make more personalized treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better distinguish active inflammation from permanent scarring in Crohn's disease using MRI, leading to more personalized treatment decisions.
- What could go wrong
- This is an early, small study on tissue already removed during surgery, not a treatment trial. The findings may not translate directly to living patients or change current care soon.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults (≥18 years) diagnosed with Crohn's disease who are undergoing planned intestinal resection surgery at CHRU Nancy.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years. * Diagnosis of Crohn's disease and undergoing intestinal resection surgery at CHRU Nancy. * Patient has not objected to the reuse of personal data and biological samples for the purposes of this research. Exclusion Criteria: \- None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Crohn disease (CD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHRU Nancy
Vandœuvre-lès-Nancy, 54511, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Non-Interventional pilot study to explore the role of gut flora in disease
- Triple-Pronged attack on gut inflammation put to the test
- Can tissue clues predict which Crohn's patients relapse after surgery?
- Exercise as a potential remedy for IBD-related fatigue
- AI reads capsule endoscopy videos to hunt for Crohn's lesions
- Can a simple ultrasound replace MRI for fistula diagnosis?